SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wynder EL, MacCornack FA, Stellman SD. The epidemiology of breast cancer in 785 United States Caucasian women. Cancer 1978; 41: 2341-54.
  • 2
    Bosland MC. Diet and cancer of the prostate: epidemiological and experimental evidence. Volume 1. Boca Raton, FL: CRC Press, 1986:125-50.
  • 3
    Ota DM, Copeland EM, Strobel HW. The effect of protein nutrition on host and tumor metabolism. J Surg Res 1977; 22: 181-8.
  • 4
    Heys SD, Park KGM, McNurlan MA, Milne E, Eramin O, Wernerman J, et al. Stimulation of protein synthesis in human tumors by parenteral nutrition: evidence for modulation of tumor growth. Br J Surg 1991; 78: 483-7.
  • 5
    Buzby GP, Mullen JL, Stein PT. Host-tumor interaction and nutrient supply. Cancer 1980; 45: 2940-8.
  • 6
    Theologides A. Pathogenesis of cachexia and cancer: a review and a hypothesis. Cancer 1972; 29: 484-8.
  • 7
    Daly JM, Copeland EM, Dudrick SJ. Effects of intravenous nutrition on tumor growth and host immunocompetence in malnurished animals. Surgery 1978; 84: 655-8.
  • 8
    Popp MB, Wagner SC, Brito OJ. Host and tumor responses to increasing levels of intravenous nutritional support. Surgery 1983; 94: 300-8.
  • 9
    Torosian MH, Tsou KC, Daly JM, Mullen JL, Stein TP, Miller EE, et al. Alteration of tumor cell kinetics by pulse total parenteral nutrition. Cancer 1984; 53: 1409-15.
  • 10
    Souba WW, Copeland EM. Hyperalimentation in cancer. Cancer 1989; 39: 105-14.
  • 11
    Istfan NW, Wan JM, Bistrian BB. Nutrition and tumor promotion: in vivo methods for measurement of cellular proliferation and protein metabolism. JPEN J Parenter Enteral Nutr 1992; 16:6 (Suppl): 76S-82S.
  • 12
    Cave WT. Differential effects of specific types of dietary lipid on mammary tumor development. In: AbrahamS, editor. Carcinogenesis and dietary fat. Boston: Kluwer, 1992: 85-99.
  • 13
    Kidwell WR, Monaco ME, Wicha MS, Smith GS. Unsaturated fatty acid requirements for growth and survival of a rat mammary tumor cell line. Cancer Res 1978; 38: 4091-100.
  • 14
    Wicha MS, Liotta LA, Kidwell WR. Effects of free fatty acids on the growth of normal and neoplastic rat mammary epithelial cells. Cancer Res 1979; 39: 426-35.
  • 15
    Marnett LJ. Polycyclic aromatic hydrocarbon oxidation during prostaglandin biosynthesis. Life Sci 1981; 29: 531-46.
  • 16
    Stahl RA, Thaiss F, Haberstoh U. Cyclooxygenase inhibition enhances rat IL-1 beta induced growth of rat mesangial cells in culture. Am J Physiol 1990; 259: F429-34.
  • 17
    Uribe A, Garberg L. Prostaglandin E2-induced hyperplasia of the rat antral epithelium is followed by a secondary inhibition of the mitotic activity. Prostaglandins 1990; 40: 1-11.
  • 18
    Simopoulos AP, Kifer RR, Martin RE, Barlow SM, editors. Health effects of ω-3 polyunsaturated fatty acids in seafoods. World Rev Nutr Diet 1991; 66: 488-503.
  • 19
    Ling PR, Istfan NW, Lopes SM, Babayan VK, Blackburn GL, Bistrian BR. Structured lipid made from fish oil and medium chain triglycerides alters tumor and host metabolism in Yoshida sarcoma-bearing rats. Am J Clin Nutr 1991; 53: 1177-84.
  • 20
    Karmali RA. Omega-3 FA and cancer: a review. In: LandsWEM, editor. Polyunsaturated fatty acids and eicosanoids. Champaign: AOCS, 1987: 222-33.
  • 21
    Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, Van Der Meer JWM, et al. The effect of dietary supplementation with (n-3) polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265-73.
  • 22
    Karnofsky DA, Burchenal GH. The clinical evaluation of chemotherapeutic agents in cancer. In: McLeodCM, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press, 1949: 191-205.
  • 23
    Osborne CK, Coronado EB, Robinson JP. Human breast cancer in the athymic nude mouse: cytostatic effect of long term anti-estrogen therapy. Eur J Cancer Clin Oncol 1987; 23: 1189.
  • 24
    Pawson T. Growth factors, oncogenes and breast cancer. In: PatersonAHG, LeesAW, editors. Fundamental problems in breast cancer. Boston: Martinus Nijhoff, 1987: 155-71.
  • 25
    Marnett LJ. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 1992; 52: 5575-89.
  • 26
    Todorof P, Cariuk P, McDevitt T, Coles B, Fearon K, Tisdale M. Characterization of a cancer cachectic factor. Nature 1996; 379: 739-42.
  • 27
    Aderka D, Fischer S, Levo Y, Holtman H, Hahn T, Wallach D. Cachectin/tumor necrosis factor production in human cancer. Lancet 1985; 2: 1190-1.
  • 28
    Meydanni SN, Lichtenstein AH, Cornwall S. Immunological effects of NCEP Step-2 diets: effects of n-3 fatty acids. FASEB J 1992; 6: A1370.
  • 29
    Stemmermann GN, Nomura AMY, Heilbrun LK. Dietary fat and the risk of colorectal cancer. Cancer Res 1984; 44: 4633-7.
  • 30
    Klurfeld DM, Weber MM, Kritchevsky D. Inhibition of chemically induced mammary and colon tumor promotion: caloric restriction in rats fed increased dietary fat. Cancer Res 1987; 47: 2759-62.
  • 31
    Begin ME, Ells G, Das UN, Horrobin DF. Differential killing of human carcinoma cells by n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst 1986; 77: 1053-9.
  • 32
    Tisdale MJ. Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia. Nutrition 1996; 12: S31-3.
  • 33
    Marshall LA, Johnston PV. Effect of dietary a-linolenic acid in the rat on fatty acid profiles of immunocompetent cell populations. Lipids 1983; 18: 737-42.
  • 34
    Lundholm K, Gelin J, Hyltander A, Lonnroth C, Sansdroem R, Svaninger G. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 1994; 54: 5602-6.
  • 35
    Wigmore SJ, Ross JA, Falconer JS, Plester CE, Tisdale MJ, Carter DC, et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 1996; 12: S27-30.